Zyneyro is a spin-out from the University of Copenhagen and Marigold Innovation developing next-generation therapies for chronic pain without the typical side effects. Built on 15 years of pioneering neuroscience research, our PICK1-targeting platform addresses the neuronal changes driving chronic pain. Our lead peptide program, ZYN01, aims to deliver rapid, reversible and safer pain relief without the limitations of current treatments.
| Website | http://www.zyneyro.com |
| Employees | 12 (6 on RocketReach) |
| Founded | 2021 |
| Industry | Biotechnology Research |
| Competitors | Concentra, UNITEDHEALTHCARE INSURANCE COMPANY, Thermo Fisher Scientific, Quest Diagnostics, Labcorp, BioReference Laboratories, Alere Inc., NMS Labs, Psychemedics Corporation, Medtox Laboratories +34 more (view full list) |
Looking for a particular Zyneyro employee's phone or email?
Zyneyro Questions
Steen Klysner is the CEO of Zyneyro.
6 people are employed at Zyneyro.
Top Zyneyro Employees
-
Steen Klysner
Chief Executive Officer at Zyneyro
Copenhagen, DK11 -
Kenneth Madsen
Co-Founder and part time CDO at Zyneyro
Copenhagen, DK -
Gith Noes-Holt
Senior Scientist at Zyneyro
Copenhagen, DK -
Kathrine Jensen
Senior Scientist at Zyneyro
Copenhagen, DK -
Marie Topp
Scientist at Zyneyro
Denmark
G2Crowd Trusted
300K+
Plugin Users
